Enjoy complimentary customisation on priority with our Enterprise License!
The coronary artery bypass grafting market size is forecast to increase by USD 30.3 million, at a CAGR of 4.49% between 2023 and 2028.
Explore in-depth regional segment analysis with market size data - historical 2018-2022 and forecasts 2024-2028 - in the full report.
Request Free Sample
The coronary artery bypass grafting (CABG) market continues to evolve, driven by advancements in surgical techniques, anesthesia management, and postoperative care. Off-pump CABG, which minimizes the use of cardiopulmonary bypass, has gained popularity due to its potential benefits in reducing complications and improving patient outcomes. Myocardial revascularization, a key application of CABG, enables the restoration of blood flow to the heart muscle, addressing coronary artery disease and enhancing long-term survival. Anticoagulation therapy plays a crucial role in preventing graft failure and thrombosis, while surgical instruments and aortocoronary bypass techniques facilitate precise and efficient procedures. Angiographic assessment is essential for evaluating graft patency and identifying potential complications such as graft stenosis or bypass conduit failure.
Surgical planning, perfusion techniques, and wound healing are critical components of the CABG process, with infection control and patient selection criteria playing a significant role in minimizing complications and optimizing outcomes. The ongoing research and development in this field continue to unfold, with minimally invasive CABG, radial artery grafts, and internal mammary artery usage emerging as potential game-changers. The evolving nature of CABG market dynamics encompasses various aspects, including ventricular function, reoperation rates, quality of life, and surgical mortality rates. As the market continues to progress, graft patency, bypass surgery complications, and graft failure remain key areas of focus for researchers and healthcare providers alike.
Hypothermic cardioplegia and saphenous vein graft disease are ongoing challenges that require continuous attention and innovation.
The coronary artery bypass grafting industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.
The on-pump segment is estimated to witness significant growth during the forecast period.
The global Coronary Artery Bypass Grafting (CABG) market is witnessing significant advancements, with a focus on enhancing patient outcomes and reducing complications. Anesthesia management plays a crucial role in ensuring a smooth surgical experience, particularly during off-pump CABG procedures, which minimize the risk of postoperative complications. Myocardial revascularization, a key component of CABG, is achieved through various techniques, including aortocoronary bypass and internal mammary artery grafting. Anticoagulation therapy is essential to prevent graft failure and thrombosis, while surgical instruments and perfusion techniques facilitate efficient grafting and wound healing. Angiographic assessment is critical for evaluating graft patency and identifying graft stenosis or bypass conduit failure.
Infection control measures are integral to minimizing surgical site infections and improving long-term survival rates. Patient selection criteria, surgical planning, and minimally invasive CABG techniques are driving innovation in the CABG market. Hypothermic cardioplegia, a technique used to protect the heart during surgery, and blood management strategies contribute to reducing surgical mortality rates and improving quality of life. However, complications such as vein graft disease, reoperation rates, and ventricular function issues remain challenges. Surgical techniques, such as radial artery grafting and saphenous vein grafting, continue to evolve, while graft patency and bypass surgery complications remain areas of ongoing research.
Infection control, patient selection, and surgical planning are essential factors influencing the market's dynamics. The CABG market is expected to grow as advancements in technology and surgical techniques improve patient outcomes and reduce complications.
The On-pump segment was valued at USD 46.80 million in 2018 and showed a gradual increase during the forecast period.
North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.
The Coronary Artery Bypass Grafting (CABG) market in North America is currently leading the global landscape due to several factors. The presence of advanced healthcare infrastructure, highly skilled medical professionals, and extensive healthcare insurance coverage are key contributors to the region's dominance. Furthermore, increasing R&D expenditure by companies, high adoption of technologically advanced products, and the availability of less invasive treatment options, such as off-pump CABG and minimally invasive CABG, are propelling market growth. In the US, the Centers for Medicare & Medicaid Services (CMS) provide extensive healthcare insurance coverage, making it the major revenue contributor to the North American CABG market.
Myocardial revascularization procedures, including CABG, are crucial for managing coronary artery disease (CAD) and improving long-term survival rates. Surgical planning, perfusion techniques, and angiographic assessment play a vital role in ensuring successful CABG outcomes. Anticoagulation therapy and infection control are essential aspects of postoperative recovery and patient care. The market also focuses on addressing complications, such as graft failure, graft stenosis, and surgical mortality rates, through advancements in bypass conduits, surgical techniques, and blood management. The goal is to enhance patient quality of life and reduce reoperation rates while maintaining optimal ventricular function and minimizing complications. Patient selection criteria and surgical mortality rates are critical factors influencing market dynamics.
Hypothermic cardioplegia and saphenous vein grafts are commonly used techniques, while internal mammary artery grafts offer better long-term patency. The market is also addressing challenges related to vein graft disease and arterial graft complications through ongoing research and development efforts.
Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.
The Coronary Artery Bypass Grafting (CABG) market continues to evolve with advancements in surgical techniques and technologies aimed at improving patient outcomes and reducing postoperative complications. One such innovation is the use of left anterior descending artery bypass, which enhances myocardial perfusion and reduces ischemic damage. Improved myocardial perfusion techniques, such as selective cannulation and antegrade cerebral perfusion, further minimize complications. Minimally invasive CABG techniques, including off-pump and robotic-assisted procedures, offer benefits like less trauma, faster recovery, and lower risk of stroke and atrial fibrillation. The impact of radial artery graft patency on long-term outcomes is significant, as it increases graft durability and reduces the need for repeat revascularization. Effective management of cardiopulmonary bypass, including optimal temperature control and hemodynamic stability, plays a crucial role in enhancing surgical outcomes for CABG patients. Patient selection criteria, such as age, comorbidities, and coronary anatomy, are essential in determining the success of the procedure. Graft stenosis detection methods, including intravascular ultrasound and angiography, help identify and address early signs of graft failure. Risk factors for graft failure, such as diabetes, smoking, and hypertension, should be carefully managed to ensure optimal graft function. Postoperative cognitive dysfunction is a common concern for CABG patients, and enhanced recovery protocols, including early mobilization and multimodal analgesia, can help minimize its impact. Assessment of ventricular function, using techniques like ejection fraction and cardiac output monitoring, allows for timely intervention in cases of postoperative heart failure. Management of postoperative bleeding, through techniques like hemostatic agents and blood salvage, and prevention of graft thrombosis, using anticoagulation and antiplatelet therapy, are essential in reducing morbidity and mortality. Minimizing surgical site infection through strict sterile technique and prophylactic antibiotics is another critical aspect of CABG care. The surgical experience of the healthcare team significantly influences CABG outcomes. Adherence to evidence-based practices and continuous professional development are essential in maintaining high-quality care and improving patient outcomes in the market.
The coronary artery bypass grafting market forecasting report includes the adoption lifecycle of the market, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the coronary artery bypass grafting market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.
Customer Landscape
Companies are implementing various strategies, such as strategic alliances, coronary artery bypass grafting market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the industry.
Abbott Laboratories - The Graftmaster RX brand, under the company's portfolio, specializes in providing coronary artery bypass grafting solutions.
The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
Dive into Technavio's robust research methodology, blending expert interviews, extensive data synthesis, and validated models for unparalleled Coronary Artery Bypass Grafting Market insights. See full methodology.
|
Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
141 |
|
Base year |
2023 |
|
Historic period |
2018-2022 |
|
Forecast period |
2024-2028 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 4.49% |
|
Market growth 2024-2028 |
USD 30.3 million |
|
Market structure |
Fragmented |
|
YoY growth 2023-2024(%) |
4.21 |
|
Key countries |
US, China, Russia, Canada, and India |
|
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
We can help! Our analysts can customize this coronary artery bypass grafting market research report to meet your requirements.
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product Type
7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Opportunity/Restraints
10 Competitive Landscape
11 Competitive Analysis
12 Appendix
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
Secondary sources
DATA ANALYSIS
Data Synthesis
Data Validation
REPORT WRITING
Qualitative
Quantitative
Get the report (PDF) sent to your email within minutes.
Complimentary full Excel data with your report purchase.
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.
